A bibliometric analysis of gene editing and amyotrophic lateral sclerosis (from 2004 to 2024)

被引:0
作者
Wan, Hejia [1 ,2 ]
Qian, Wenli [1 ,3 ]
Wei, Bingqi [1 ,4 ]
Tian, Kaiyue [1 ,4 ]
Chen, Ziyi [1 ,4 ]
Zhang, Jiong [1 ]
Chen, Fang [1 ]
机构
[1] Henan Univ Chinese Med, Sch Med, Zhengzhou, Peoples R China
[2] Henan Univ Chinese Med, Sch Nursing, Zhengzhou, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Sch Humanities & Social Sci, Beijing, Peoples R China
[4] Henan Univ Chinese Med, Sch Chinese Med, Zhengzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
amyotrophic lateral sclerosis; gene editing technology; bibliometric study; CiteSpace; VOSviewer; MOTOR-NEURON DEGENERATION; MECHANISMS; MUTATIONS; SOD1;
D O I
10.3389/fnins.2024.1499025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective To learn more about gene editing and ALS, and to provide a comprehensive view of gene editing for further treatment of amyotrophic lateral sclerosis.Methods We searched 1981 records from Web of Science core collection and Pubmed, Scopus, of which 1,292 records were obtained after exclusion. We then scientifically and metrologically analyzed these records for spatial and temporal distribution, author distribution, subject categories, subject distribution, references, and keywords using R, software CiteSpace and VOSviewer.Results Our analysis provides basic information about research in the field, suggests that the field has stabilized over the past decade, and identifies potential partners for interested researchers. Current research in this area is focused on inflammatory mechanisms, immune mechanisms, related diseases, and associated cytokines in ALS.Conclusion RNA Editing, Antisense Bligonucleotide, and Glycine Receptor are cutting-edge research topics in this field, which is undergoing rapid development. We hope that this work will provide new ideas for advancing the scientific research and clinical application of ALS.
引用
收藏
页数:15
相关论文
共 52 条
  • [1] Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
    Abati, Elena
    Bresolin, Nereo
    Comi, Giacomo
    Corti, Stefania
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (04) : 295 - 310
  • [2] Antisense oligonucleotides (ASOs) in chronic hepatitis B infection: Opportunities and challenging the orthodoxy
    Agarwal, Kosh
    Lok, James
    Gane, Ed
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 906 - 908
  • [3] Gene therapy for ALS: A review
    Amado, Defne A.
    Davidson, Beverly L.
    [J]. MOLECULAR THERAPY, 2021, 29 (12) : 3345 - 3358
  • [4] Balendra R, 2016, LANCET, V387, P13
  • [5] Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review
    Berry, James D. D.
    Blanchard, Marie
    Bonar, Kerina
    Drane, Emma
    Murton, Molly
    Ploug, Uffe
    Ricchetti-Masterson, Kristen
    Savic, Natasa
    Worthington, Emma
    Heiman-Patterson, Terry
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2023, 24 (5-6) : 436 - 448
  • [6] Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.85]
  • [7] Unraveling the mechanisms involved in motor neuron degeneration in ALS
    Bruijn, LI
    Miller, TM
    Cleveland, DW
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2004, 27 : 723 - 749
  • [8] Chen Chaomei, 2020, Front Res Metr Anal, V5, P607286, DOI 10.3389/frma.2020.607286
  • [9] Ethics of Human Genome Editing
    Coller, Barry S.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 289 - 305
  • [10] Dynamic structures and emerging trends in the management of major trauma: A bibliometric analysis of publications between 2012 and 2021
    Du, Zhe
    Wang, Zhenzhou
    Guo, Fuzheng
    Wang, Tianbing
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10